Icon

Wanjia Group Holdings Ltd Stock Analysis and Price Target COMMON STOCK | Medical Distribution | HK

N/A

Average User
Rating

N/A

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis

HKD 0.16

0.00 (0.00)%

HKD 0.09B

0.20M

N/A

N/A

Icon

0401:HK

Wanjia Group Holdings Ltd (HKD)
COMMON STOCK | HK
HKD 0.16
0.00 0

N/A

Average User
Rating

N/A

Average Analyst
Rating

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis

HKD 0.09B

N/A

HKD 0.16

Wanjia Group Holdings Ltd Stock Forecast

N/A

Based on the Wanjia Group Holdings Ltd stock forecasts from 0 analysts, the average analyst target price for Wanjia Group Holdings Ltd is not available over the next 12 months. Wanjia Group Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Wanjia Group Holdings Ltd is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Wanjia Group Holdings Ltd’s stock price was HKD 0.16. Wanjia Group Holdings Ltd’s stock price has changed by +1.91% over the past week, +1.91% over the past month and +6.67% over the last year.

No recent analyst target price found for Wanjia Group Holdings Ltd
No recent average analyst rating found for Wanjia Group Holdings Ltd

Company Overview

Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals...Read More

https://www.wanjia-gp.com

Tower 1, Kowloon, Hong Kong

192

March

HKD

Hong Kong

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Wanjia Group Holdings Ltd (Sector: Medical Distribution )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
2607:HK
Shanghai Pharmaceuticals Holdi.. 0.00 (0.00%) HKD78.98B 7.97 6.95

ETFs Containing 0401

Symbol Name Weight Mer Price(Change) Market Cap
no data

Frequently Asked Questions About 0401:HK Stock

Stock Target Advisor's fundamental analysis for Wanjia Group Holdings Ltd's stock is Slightly Bearish.

Unfortunately we do not have enough data on 0401:HK's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 0401:HK's stock to indicate what its average analyst target is.

0401:HK stock's Price/Earning ratio is 1,337.76. Our analysis grades 0401:HK stock's Price / Earning ratio at F. This means that 0401:HK stock's Price/Earning ratio is above 87% of the stocks in the Medical Distribution sector in the HK exchange. Based on this 0401:HK may be a overvalued for its sector.

The last closing price of 0401:HK's stock was HKD 0.16.

The most recent market capitalization for 0401:HK is HKD 0.09B.

Unfortunately we do not have enough analyst data on 0401:HK's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...